Loading clinical trials...

Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients | Clinical Trials | Clareo Health

RECRUITINGNA

Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients

Electrical Stimulation for Respiratory and Leg Muscles Impact on Pulmonary Function and Leg Restless Syndrome in COPD Patients

NCT06670443•Cairo University

View on ClinicalTrials.gov

Summary

Electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles In addition to conventional pulmonary rehabilitation

Detailed Description

Intervention group: active NMES (350 μs pulses - 50 Hz frequency) will be applied at the lower third of the thigh, just above the patella, and the proximal electrode 5-10 cm below the anterior superior iliac spine for quadriceps muscle stimulation, and for intercostal muscles stimulation, NMES will be bilaterally, parallel to the ribs, in the intercostal space. The proximal electrode will be positioned close to the sternum, and the distal electrode laterally, close to the midaxillary line. In addition to conventional pulmonary rehabilitation program that comprised diaphragmatic and pursed lips breathing. control group: placebo NMES at the same points in addition to the same conventional pulmonary rehabilitation program

Eligibility

Age

40 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG) including
•1. an urge to move legs that is usually associated with paresthesia.
•2. alleviation of the symptoms by moving the legs.
•3. aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed.
•4. worsening of the signs at night. patients with diagnosed with grade I and grade II COPD their ages ranged between 45-55 o All patients will be clinically and medically stable when attending the study

Exclusion Criteria

•History of Deep venous thrombosis
•* History of Bleeding disorders
•* Have an implantable device like a pacemaker
•* Recent Infected wound
•* History of allergic response to the electrodes, gel or tape
•* patients who participating in any other exercise program
•* Loss of sensation or numbness

Locations (1)

Faculty of Physical Therapy

Dokki, Egypt

Key Dates

Start Date

January 10, 2025

Primary Completion Date

November 30, 2025

Completion Date

December 30, 2025

Last Updated

September 15, 2025

Enrollment

ESTIMATED participants

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

experimental group

DEVICE

control group

DEVICE

Contacts

mushabab alahmari, phd

CONTACT

563920029 malahmarirrt@gail.com

marwa mahmoud, phd

CONTACT

01156033818 marwadd999@gmail.com

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGPHASE3

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

Chronic Obstructive Pulmonary Disease

View study

RECRUITINGNA

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Probiotics in Pulmonaty Rehabilitation for COPD

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease